It takes two: The relative contributions of parent versus child-led regulatory behaviours on toddler vaccination pain

BACKGROUND

Past research has established the important role of parent soothing in early childhood pain management. However, limited research has assessed children's own emerging emotion regulation strategies to reduce their pain during vaccination. The purpose of the current study was to understand the relative contributions of child-led emotion-regulation behaviours over and above parent regulatory behaviours and pre-needle distress.

METHODS

Toddler-caregiver dyads were videotaped at their 12- and/or 18-month vaccinations. Videos were coded for pain-related behavioural distress, child-led regulatory behaviours (disengagement of attention, parent-focused behaviours, and physical self-soothing), and parent regulatory/soothing behaviours (distraction, physical comfort, rocking, verbal reassurance). Pre-needle distress, followed by parent regulatory behaviours, followed by child regulatory behaviours were used as hierarchical predictors of pain regulation. Two sets of models were estimated at each age, by incorporating parent and child regulatory behaviours at 1 min and 2 min post-needle, separately.

RESULTS

At both ages, child-led parent-focused behaviours predicted less regulation. At 18 months, parent soothing behaviours (e.g. distraction, verbal reassurance, rocking) played a stronger role in regulation, however; the only behaviour that increased regulation was rocking.

CONCLUSIONS

Measuring both parent and child regulatory behaviours was important for fully understanding pain-related distress regulation. Toddlers' use of parent-focused regulatory behaviours (e.g. proximity seeking) suggests that they signal to their parent directly when they are struggling to regulate post-needle. The only parent behaviour that supported this regulation was rocking at 18 months, suggesting a greater need to understand the sensitivity of parent behaviours post-needle.

SIGNIFICANCE

To our knowledge, this is the first study to examine both parent and child regulatory behaviours following vaccination at different stages in toddlerhood. This investigation allows a deeper understanding of the dyadic nature of early childhood vaccination, as well as the evolving role of the parent through toddlerhood. Importantly, findings suggest that toddlers do not simply wait for their parents to respond to their pain post-needle and provide clear signals to show their need of support in regulation.

Screening of males with eating disorders

The purpose of this study was to evaluate two different questionnaires for screening of eating disorders (ED) in males; the Eating Disorders Inventory (EDI) and the Survey for Eating Disorders (SEDs). The study sample consisted of 1196 Norwegian males serving as compulsory military recruits (mean age 19.9, SD = 1.4). The best predictors for having a SEDs-based diagnosis of ED were the EDI scales Drive for thinness (D7), bulimia (B), ineffectiveness (I) and interpersonal awareness (IA). When we classified men with an EDI sum score of 40 or higher as having an ED, the sensitivity was 47% and the specificity was 91%, compared to the SEDs diagnosis of ED. Our results suggest modest agreement between the ability of the EDI and that of the SEDs to identify men with ED. Our results indicate the need of further studies including clinical samples to validate the EDI against the SEDs.

Intentional weight loss and mortality among overweight individuals with diabetes

OBJECTIVE

To estimate the effect of intentional weight loss on mortality in overweight individuals with diabetes.

RESEARCH DESIGN AND METHODS

We performed a prospective analysis with a 12-year mortality follow-up (1959-1972) of 4,970 overweight individuals with diabetes, 40-64 years of age, who were enrolled in the American Cancer Society's Cancer Prevention Study I. Rate ratios (RRs) were calculated, comparing overall death rates, and death from cardiovascular disease (CVD) or diabetes in individuals with and without reported intentional weight loss.

RESULTS

Intentional weight loss was reported by 34% of the cohort. After adjustment for initial BMI, sociodemographic factors, health status, and physical activity, intentional weight loss was associated with a 25% reduction in total mortality (RR = 0.75; 95% CI 0.67-0.84), and a 28% reduction in CVD and diabetes mortality (RR = 0.72; 0.63-0.82). Intentional weight loss of 20-29 lb was associated with the largest reductions in mortality (approximately 33%). Weight loss >70 lb was associated with small increases in mortality

CONCLUSIONS

Intentional weight loss was associated with substantial reductions in mortality in this observational study of overweight individuals with diabetes.

Interaction between somatic and vagal afferent inputs in control of ventilation in 2-week-old rabbits

Effects of saphenous nerve stimulation (SNS) on the Hering-Breuer expiratory-promoting reflex evoked by a positive tracheal pressure (PTR; 5 cmH2O) and on the diaphragmatic EMG (EMG(DI)), inspiratory (TI) and expiratory (TE) time, were studied in 16 urethane-anesthetized (1.2-1.6 g/kg, i.p.) spontaneously breathing 2-week-old rabbits. Positive P(TR) applied at the end of T(I) increased the subsequent TE to 255+/-29% (+/-S.E.; P < 0.0001) of control. SNS (1 sec train, 2 msec pulse, 6 Hz) applied at the onset of TE, shortened this TE by 42+/-3% (P < 0.0001). When SNS preceded positive PTR or positive PTR preceded SNS, the TE increased to 163+/-20 and 184+/-21% of control, respectively. These responses were not different, and smaller than that provoked by the PTR test alone (P < 0.003 and 0.05, respectively). The results show that in newborns somatic afferent stimulation attenuates the vagally mediated respiratory inhibition, whether immediately before or during the vagal stimulation.

Prospective study of intentional weight loss and mortality in overweight white men aged 40-64 years

Although 25% of US men indicate that they are trying to lose weight, the association between intentional weight loss and longevity in men is unknown. The authors analyzed prospective data from 49,337 overweight (initial body mass index > or =27) white men aged 40-64 years who, in 1959-1960, answered questions on weight change direction, amount, time interval, and intent. Vital status was determined in 1972. Proportional hazards regression estimated mortality rate ratios for men who intentionally lost weight compared with men with no weight change. Analyses were stratified by health status and adjusted for age, initial body mass index, smoking status, alcohol intake, education, physical activity, health history, and physical symptoms. Among men with no reported health conditions (n = 36,280), intentional weight loss was not associated with total, cardiovascular (CVD), or cancer mortality, but diabetes-associated mortality was increased 48% (95% confidence interval (CI) -7% to +133%) among those who lost 20 pounds (9.1 kg) or more; this increase was largely related to non-CVD mortality. Among men with reported health conditions (n = 13,057), intentional weight loss had no association with total or CVD mortality, but cancer mortality increased 25% (95% confidence interval -4% to +63%) among those who lost 20 pounds or more. Diabetes-associated mortality was reduced 32% (95% confidence interval -52% to -5%) among those who lost less than 20 pounds and 36% (95% confidence interval -49% to -20%) among those who lost more than 20 pounds. These results and those from our earlier study in women (Williamson et al., Am J Epidemiol 1995;141:1128-41) suggest that intentional weight loss may reduce the risk of dying from diabetes, but not from CVD. In observational studies, however, it is difficult to separate intentional weight loss from unintentional weight loss due to undiagnosed, underlying disease. Well-designed observational studies, as well as randomized controlled trials, are needed to determine whether intentional weight loss reduces CVD mortality.

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

Although 40% of US women indicate they are currently trying to lose weight, the association between intentional weight loss and longevity is unknown. The authors analyzed prospective data from 43,457 overweight, never-smoking US white women aged 40-64 years who in 1959-1960 completed a questionnaire that included questions on weight change direction, amount, time interval, and intentionality. Vital status was determined in 1972. Proportional hazards regression was used to estimate mortality rate ratios for women who intentionally lost weight compared with women who had no change in weight. Women who died within the first 3 years of follow-up were excluded. Analyses were stratified by preexisting illness and adjusted for age, beginning body mass index, alcohol intake, education, physical activity, and health conditions. In women with obesity-related health conditions (n = 15,069), intentional weight loss of any amount was associated with a 20% reduction in all-cause mortality, primarily due to a 40-50% reduction in mortality from obesity-related cancers; diabetes-associated mortality was also reduced by 30-40% in those who intentionally lost weight. In women with no preexisting illness (n = 28,388), intentional weight loss of > or = 20 lb (> or = 9.1 kg) that occurred within the previous year was associated with about a 25% reduction in all-cause, cardiovascular, and cancer mortality; however, loss of < 20 lb (< 9.1 kg) or loss that occurred over an interval of > or = 1 year was generally associated with small to modest increases in mortality. The association between intentional weight loss and longevity in middle-aged overweight women appears to depend on their health status. Intentional weight loss among women with obesity-related conditions is generally associated with decreased premature mortality, whereas among women with no preexisting illness, the association is equivocal.

Retrospective study of the impact of lead-based paint hazard remediation on children's blood lead levels in St. Louis, Missouri

A retrospective follow-up study was conducted to evaluate the effectiveness of lead-based paint hazard remediation in reducing children's blood lead levels. The authors reviewed existing St. Louis, Missouri, City Health Department records, identified 185 children younger than age 6 years who had blood lead levels > or = 25 micrograms/dl during 1989 or 1990, and compared changes in blood lead levels among children whose dwellings did and those whose dwellings did not undergo remediation. Among 54 children who had not moved or received chelation therapy and whose blood lead levels were measured 10-14 months after diagnosis, the geometric mean blood lead level decreased 23% among children living in remediated dwellings (n = 37) and 12% among children in nonremediated dwellings (n = 17) (p = 0.07, t test). The estimated size of the remediation effect was similar using multiple regression (-13%; 95% confidence interval (CI) -25 to 1; p = 0.06) and an approach based on generalized estimating equations (-16%, 95% CI -25 to -7; p = 0.002), when adjusted for covariates. The effect of remediation was greater among children whose blood lead levels at diagnosis were > or = 35 micrograms/dl (-22%) than among those whose blood lead levels at diagnosis were between 25 and 34 micrograms/dl (-1%). Among lead-poisoned children in St. Louis, children whose dwellings undergo lead-based paint hazard remediation have a greater decline in geometric mean blood lead level than do children whose dwellings do not, but the effect of remediation may be influenced by the blood lead level at diagnosis.

Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. Black/White Cancer Survival Study Group

BACKGROUND

Studies in the United States have reported that Black women have higher fatality rates than White women following a diagnosis of breast cancer and are more likely to be diagnosed with late-stage cancers.

PURPOSE

To evaluate reasons for these racial differences, we explored the difference between Black and White women in the length of time from symptom recognition to initial medical consultation. We also evaluated the extent to which other factors related to the length of this interval might contribute to any observed racial difference.

METHODS

As part of a collaborative study of differences in the survival rates of Black patients and White patients with cancer, we interviewed a sample of 410 Black women and 325 White women from Atlanta, New Orleans, and San Francisco/Oakland who were newly diagnosed in 1985 or 1986 with invasive breast cancer. Retrospective data were collected on symptoms, dates of symptom recognition and initial medical consultation, and several other factors which may affect the interval between symptom recognition and medical consultation. Data were analyzed as if from a follow-up study, using product limit procedures and proportional hazards regression.

RESULTS

At diagnosis, Black women with breast cancer were two times more likely to have stage IV breast cancer and one and one-half times more likely to have stage III breast cancer than White women with breast cancer and were only approximately one-half as likely to have stage I breast cancer. Similarly, Black women were almost twice as likely as White women to have tumors that were larger than 5 cm or tumors that had extensions to the chest wall or skin at presentation. However, the average rate at which Black women with breast cancer obtained an initial medical consultation lagged behind that for White women by only a slight but statistically significant difference (15%). The median time between symptom recognition and medical consultation was slightly longer for Black women (16 days) than for White women (14 days) (P = .06). Adjustment for other characteristics predictive of the length of this interval had little effect on racial differences. The racial differences tended to vary somewhat by age and metropolitan area, suggesting that the results may not apply equally to all demographic subgroups and regions in the United States.

CONCLUSION

This small difference in the time from symptom recognition to medical consultation is unlikely to account for the large racial differences in survival rates and in stage of disease at the time of diagnosis.